P-587 Experience from a large multi-centre expanded access programme (EAP) with gefitinib (‘Iressa’, ZD1839) as monotherapy in advanced non-small cell lung cancer (NSCLC)

✍ Scribed by van Puijenbroek, R.; Bosquée, L.; Tits, G.; Germonpre, P.; Strobbe, E.; Vansteenkiste, J.

• Book ID: 118573491
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 294 KB
• Volume: 49
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/s0169-5002(05)81080-3